Key Findings
Global equivalent sales volume reached approximately 180 liters in 2025 and is estimated at about 220 liters in 2026
Average selling prices remain close to US$70,000 per liter due to low-volume and high-value bioprocess economics
Pan-serotype and multi-serotype products are gaining importance in platform-based AAV purification development
North America remains the largest demand center while China is expanding localized supply and second-source validation
Competition remains concentrated among a limited number of technically validated global and Chinese manufacturers
AAV Affinity Chromatography Resins Market Size(US$)

CAGR 2026-2032
13.3%
Market Size,2032
USD 32.06
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for AAV Affinity Chromatography Resins was estimated to be worth US$ 13.06 million in 2025 and is projected to reach US$ 32.06 million, growing at a CAGR of 13.3% from 2026 to 2032.
AAV Affinity Chromatography Resins are high-value bioprocess chromatography media designed for the selective capture and primary purification of adeno-associated virus capsids during viral vector manufacturing. These products immobilize AAV-binding ligands, including single-domain antibodies, recombinant proteins, engineered protein scaffolds and synthetic peptides, onto cross-linked agarose or rigid polymer bead matrices. Commercial products are supplied mainly as loose bulk resins and prepacked columns, with validated formats ranging from milliliter-scale process-development packs to multi-liter manufacturing volumes. Key performance parameters include serotype coverage, dynamic binding capacity, pressure-flow behavior, recovery, impurity clearance, elution conditions, alkaline cleaning tolerance, ligand leakage and reusable cycle life. The market covers pan-serotype, limited multi-serotype and serotype-specific products used to capture AAV vectors produced through HEK293, Sf9 and other manufacturing platforms. Primary applications extend from resin screening and purification process development to clinical-stage GMP production, process validation, technology transfer, second-site qualification and commercial-scale viral vector manufacturing. As an upstream biopharmaceutical process material, AAV Affinity Chromatography Resins directly influence purification yield, process consistency, facility productivity, regulatory readiness and the overall economics of gene therapy manufacturing.
Market Trends
Market Segmentation
Market Dynamics
Drivers
Demand growth is primarily supported by the progression of AAV gene therapy programs from early clinical development into larger Phase II, Phase III and commercial manufacturing campaigns. Resin consumption per active project rises materially as processes move from screening and laboratory columns to engineering batches, validation campaigns and multi-site production. High-dose systemic therapies, expansion of viral vector CDMO capacity, qualification of backup manufacturing locations and increased use of platform purification processes further support resin demand. The requirement for higher recovery, consistent impurity removal and scalable GMP processing also encourages replacement of less selective purification approaches with dedicated AAV affinity capture steps.
Restraints
Market expansion is moderated by the small number of commercial AAV products, long development timelines and uncertainty surrounding the clinical success of individual gene therapy programs. AAV affinity resins are expensive to qualify and replace because changes to the capture step may require comparability studies, process revalidation and additional regulatory documentation. High resin prices encourage customers to optimize column loading and extend reusable cycle life, which reduces annual replacement volume. In addition, differences in feedstream quality, capsid design and production platforms can limit the transferability of performance data between projects, slowing adoption of newly launched products.
Opportunities
The strongest opportunities are emerging in affinity products for engineered capsids, broad platform resins, second-source qualification and localized GMP supply. As developers introduce novel capsids to improve tissue targeting, immune profiles and manufacturing yield, established binding ligands may lose affinity or require new process conditions. This creates demand for new ligand libraries, rapid resin screening services and product families that can move efficiently from development to commercial scale. Suppliers can also expand through integrated offerings combining loose resin, prepacked columns, process-development tools, ligand leakage assays, cleaning studies and regulatory support. China and other Asian markets offer additional opportunities as local gene therapy companies and CDMOs seek shorter lead times, lower procurement risk and alternatives to imported bioprocess materials.
Challenges
The market continues to face limited standardization in product-performance reporting. Suppliers use different units for binding capacity, including viral particles, vector genomes and capsid measurements, while residence time, feed composition and breakthrough definitions also vary. This makes direct comparison difficult and increases the burden of customer-side testing. Manufacturers must maintain consistent ligand production, coupling density, bead morphology, impurity control and lot-to-lot performance while scaling relatively small annual volumes. Commercial success also depends on building credible GMP documentation, extractables and leachables data, ligand leakage methods, cleaning validation and long-term supply commitments. Rapid changes in capsid engineering and the emergence of alternative capture formats may shorten product lifecycles and require continuous technology investment.
Industry Chain Analysis
The upstream segment of the AAV Affinity Chromatography Resins industry consists of agarose and synthetic polymer bead materials, functional monomers, cross-linking reagents, activation chemistries, spacer arms, affinity ligands and manufacturing-grade buffers. Ligand development is a particularly important source of differentiation because capsid selectivity, serotype coverage, elution behavior and alkaline stability depend strongly on ligand structure and immobilization chemistry. Matrix suppliers contribute particle-size control, pore architecture, mechanical strength and pressure-flow performance, while analytical materials and reference standards support binding, leakage and impurity testing.
The midstream segment integrates ligand discovery, matrix functionalization, coupling, washing, formulation, filling, quality control and batch release into a complete chromatography product. Value creation is concentrated in proprietary ligand technology, reproducible manufacturing, application data and regulatory support rather than in the base bead material alone. Downstream customers include gene therapy developers, biopharmaceutical companies, viral vector CDMOs, research institutions and manufacturing technology centers. These users evaluate products based on total process economics, including recovery, productivity, buffer consumption, resin lifetime, validation requirements and supply continuity. High small-pack prices support development-stage margins, while commercial contracts involve larger packaging discounts, technical service commitments and longer qualification cycles.
Segment Insights
By serotype coverage, pan-serotype and limited multi-serotype AAV affinity resins are becoming strategically important because they allow developers and CDMOs to standardize purification across multiple pipeline assets. These products are particularly valuable during early development, when capsid selection may change and a common capture platform can reduce process-development time. Serotype-specific resins remain relevant where higher selectivity, stronger binding or more favorable elution performance can be achieved for important capsids such as AAV8 and AAV9. Products with insufficiently disclosed serotype validation remain a smaller and less differentiated part of the market.
Cross-linked agarose represents the most widely used matrix route among current commercial products because of its established bioprocess acceptance and favorable hydrophilic characteristics. Rigid polystyrene divinylbenzene, polymethacrylate and polyvinyl ether matrices provide alternative pressure-flow and mass-transfer performance for higher-throughput processing. Single-domain antibody ligands are the most frequently represented affinity route in the current product landscape, while synthetic peptides, recombinant proteins and engineered protein scaffolds provide differentiated options in stability, selectivity and manufacturing control. Loose bulk resin accounts for most manufacturing-stage consumption, whereas prepacked columns and small-volume formats play a larger role in screening, process development and technology transfer.
Downstream Market Opportunities
Downstream opportunities are concentrated in process development, clinical manufacturing and commercial viral vector production. Development laboratories generate frequent but small-volume demand for serotype screening, capacity studies, cleaning evaluation and buffer optimization. Clinical-stage programs require larger quantities for engineering batches, GMP campaigns and process transfer, while late-stage and commercial projects create the highest resin demand per active program through validation, multiple production sites and planned replacement inventories. Both HEK293 and Sf9-based AAV manufacturing platforms require selective capture solutions, although differences in host-cell impurities, feed concentration and lysis conditions create distinct performance requirements. Suppliers that can demonstrate consistent results across production platforms and engineered capsids are positioned to access a broader downstream customer base.
Regional Insights

Fastest-Growing Region: Asia Pacific
North America is the largest market for AAV Affinity Chromatography Resins, supported by its concentration of gene therapy developers, clinical programs, commercial products, specialized CDMOs and established bioprocess suppliers. Demand is characterized by strong regulatory-documentation requirements, high adoption of platform processes and significant use of prepacked development and manufacturing columns. Europe remains an important market through its advanced gene therapy research base, regulated manufacturing infrastructure and expertise in ligand and chromatography technology. European customers place particular emphasis on process robustness, supply assurance and lifecycle documentation.
By Type,2021-2032(US$ Million)
Pan-Serotype AAV Affinity Resins
Limited Multi-Serotype AAV Affinity Resins
Serotype-Specific AAV Affinity Resins
Other
By Application,2021-2032(US$ Million)
HEK293-Derived AAV Purification
Sf9-Derived AAV Purification
Other
China is developing into the most important emerging supply and demand center. Domestic companies have introduced pan-serotype, multi-serotype and serotype-specific products, while local gene therapy developers increasingly assess domestic materials as primary or backup sources. The competitive advantage of Chinese suppliers is centered on local technical support, shorter lead times, flexible packaging and pricing, although broader commercial GMP references and long-term cycle data remain important qualification requirements. Japan, South Korea, India, China Taiwan and Southeast Asia currently function mainly as development, manufacturing-service, distribution or regional technical-support markets, with a limited number of independent commercial AAV affinity resin producers.
Competitive Landscape Analysis
The competitive landscape is concentrated but gradually broadening. Established multinational suppliers benefit from installed customer processes, extensive application data, global distribution, regulatory support and demonstrated batch consistency. Their products are frequently embedded in clinical and commercial manufacturing processes, creating high switching costs and long customer retention. Specialized affinity technology companies compete through novel peptide ligands, engineered scaffolds, broad serotype coverage, mild elution and improved cleaning stability. Chinese manufacturers are expanding the market through locally developed ligands, agarose and polymer matrix capabilities, broader packaging flexibility and lower regional supply risk. However, competition is determined by more than nominal product price or binding capacity. Customers assess recovery, impurity clearance, capsid compatibility, pressure-flow behavior, reuse performance, ligand leakage, lot consistency and the supplier’s ability to support regulatory filings. The market is therefore expected to remain technically selective, with successful suppliers requiring both proprietary product performance and credible long-term manufacturing support.
Report Scope
This report provides a comprehensive view of the global market for AAV Affinity Chromatography Resins, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The AAV Affinity Chromatography Resins market size, estimations, and forecasts are presented in terms of sales volume (L) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding AAV Affinity Chromatography Resins.
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the AAV Affinity Chromatography Resins manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents AAV Affinity Chromatography Resins sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents AAV Affinity Chromatography Resins sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 AAV Affinity Chromatography Resins Product Introduction
1.2 Global AAV Affinity Chromatography Resins Market Size Forecast
1.2.1 Global AAV Affinity Chromatography Resins Sales Value (2021–2032)
1.2.2 Global AAV Affinity Chromatography Resins Sales Volume (2021–2032)
1.2.3 Global AAV Affinity Chromatography Resins Sales Price (2021–2032)
1.3 AAV Affinity Chromatography Resins Market Trends & Drivers
1.3.1 AAV Affinity Chromatography Resins Industry Trends
1.3.2 AAV Affinity Chromatography Resins Market Drivers & Opportunities
1.3.3 AAV Affinity Chromatography Resins Market Challenges
1.3.4 AAV Affinity Chromatography Resins Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AAV Affinity Chromatography Resins Players Revenue Ranking (2025)
2.2 Global AAV Affinity Chromatography Resins Revenue by Company (2021–2026)
2.3 Global AAV Affinity Chromatography Resins Sales Volume Ranking of Players (2025)
2.4 Global AAV Affinity Chromatography Resins Sales Volume by Company (2021–2026)
2.5 Global AAV Affinity Chromatography Resins Average Price by Company (2021–2026)
2.6 Key Manufacturers AAV Affinity Chromatography Resins Manufacturing Base and Headquarters
2.7 Key Manufacturers AAV Affinity Chromatography Resins Product Offerings
2.8 Key Manufacturers Start of Mass Production of AAV Affinity Chromatography Resins
2.9 AAV Affinity Chromatography Resins Market Competitive Analysis
2.9.1 AAV Affinity Chromatography Resins Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by AAV Affinity Chromatography Resins Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on AAV Affinity Chromatography Resins revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation AAV Affinity Chromatography Resins Market Classification
3.1 Introduction by Type
3.1.1 Pan-Serotype AAV Affinity Resins
3.1.2 Limited Multi-Serotype AAV Affinity Resins
3.1.3 Serotype-Specific AAV Affinity Resins
3.1.4 Other
3.1.5 Global AAV Affinity Chromatography Resins Sales Value by Type
3.1.5.1 Global AAV Affinity Chromatography Resins Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global AAV Affinity Chromatography Resins Sales Value, by Type (2021–2032)
3.1.5.3 Global AAV Affinity Chromatography Resins Sales Value, by Type (%), 2021–2032
3.1.6 Global AAV Affinity Chromatography Resins Sales Volume by Type
3.1.6.1 Global AAV Affinity Chromatography Resins Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global AAV Affinity Chromatography Resins Sales Volume, by Type (2021–2032)
3.1.6.3 Global AAV Affinity Chromatography Resins Sales Volume, by Type (%), 2021–2032
3.1.7 Global AAV Affinity Chromatography Resins Average Price by Type (2021–2032)
3.2 Introduction by Matrix Material
3.2.1 Cross-Linked Agarose Resins
3.2.2 Cross-Linked Polystyrene Divinylbenzene Resins
3.2.3 Polymethacrylate Resins
3.2.4 Polyvinyl Ether Resins
3.2.5 Other
3.2.6 Global AAV Affinity Chromatography Resins Sales Value by Matrix Material
3.2.6.1 Global AAV Affinity Chromatography Resins Sales Value by Matrix Material (2021 vs 2025 vs 2032)
3.2.6.2 Global AAV Affinity Chromatography Resins Sales Value, by Matrix Material (2021–2032)
3.2.6.3 Global AAV Affinity Chromatography Resins Sales Value, by Matrix Material (%), 2021–2032
3.2.7 Global AAV Affinity Chromatography Resins Sales Volume by Matrix Material
3.2.7.1 Global AAV Affinity Chromatography Resins Sales Volume by Matrix Material (2021 vs 2025 vs 2032)
3.2.7.2 Global AAV Affinity Chromatography Resins Sales Volume, by Matrix Material (2021–2032)
3.2.7.3 Global AAV Affinity Chromatography Resins Sales Volume, by Matrix Material (%), 2021–2032
3.2.8 Global AAV Affinity Chromatography Resins Average Price by Matrix Material (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 HEK293-Derived AAV Purification
4.1.2 Sf9-Derived AAV Purification
4.1.3 Other
4.2 Global AAV Affinity Chromatography Resins Sales Value by Application
4.2.1 Global AAV Affinity Chromatography Resins Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global AAV Affinity Chromatography Resins Sales Value, by Application (2021–2032)
4.2.3 Global AAV Affinity Chromatography Resins Sales Value, by Application (%), 2021–2032
4.3 Global AAV Affinity Chromatography Resins Sales Volume by Application
4.3.1 Global AAV Affinity Chromatography Resins Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global AAV Affinity Chromatography Resins Sales Volume, by Application (2021–2032)
4.3.3 Global AAV Affinity Chromatography Resins Sales Volume, by Application (%), 2021–2032
4.4 Global AAV Affinity Chromatography Resins Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global AAV Affinity Chromatography Resins Sales Value by Region
5.1.1 Global AAV Affinity Chromatography Resins Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global AAV Affinity Chromatography Resins Sales Value by Region (2021–2026)
5.1.3 Global AAV Affinity Chromatography Resins Sales Value by Region (2027–2032)
5.1.4 Global AAV Affinity Chromatography Resins Sales Value by Region (%), 2021–2032
5.2 Global AAV Affinity Chromatography Resins Sales Volume by Region
5.2.1 Global AAV Affinity Chromatography Resins Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global AAV Affinity Chromatography Resins Sales Volume by Region (2021–2026)
5.2.3 Global AAV Affinity Chromatography Resins Sales Volume by Region (2027–2032)
5.2.4 Global AAV Affinity Chromatography Resins Sales Volume by Region (%), 2021–2032
5.3 Global AAV Affinity Chromatography Resins Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America AAV Affinity Chromatography Resins Sales Value, 2021–2032
5.4.2 North America AAV Affinity Chromatography Resins Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe AAV Affinity Chromatography Resins Sales Value, 2021–2032
5.5.2 Europe AAV Affinity Chromatography Resins Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific AAV Affinity Chromatography Resins Sales Value, 2021–2032
5.6.2 Asia Pacific AAV Affinity Chromatography Resins Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America AAV Affinity Chromatography Resins Sales Value, 2021–2032
5.7.2 South America AAV Affinity Chromatography Resins Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa AAV Affinity Chromatography Resins Sales Value, 2021–2032
5.8.2 Middle East & Africa AAV Affinity Chromatography Resins Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AAV Affinity Chromatography Resins Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions AAV Affinity Chromatography Resins Sales Value and Sales Volume
6.2.1 Key Countries/Regions AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.2.2 Key Countries/Regions AAV Affinity Chromatography Resins Sales Volume, 2021–2032
6.3 United States
6.3.1 United States AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.3.2 United States AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.3.3 United States AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.4.2 Europe AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.5.2 China AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.5.3 China AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.6.2 Japan AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.7.2 South Korea AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.8.2 Southeast Asia AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India AAV Affinity Chromatography Resins Sales Value, 2021–2032
6.9.2 India AAV Affinity Chromatography Resins Sales Value by Type (%), 2025 vs 2032
6.9.3 India AAV Affinity Chromatography Resins Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Company Information
7.1.2 Thermo Fisher Scientific Inc. Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Inc. AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Thermo Fisher Scientific Inc. AAV Affinity Chromatography Resins Product Offerings
7.1.5 Thermo Fisher Scientific Inc. Recent Developments
7.2 Danaher Corporation
7.2.1 Danaher Corporation Company Information
7.2.2 Danaher Corporation Introduction and Business Overview
7.2.3 Danaher Corporation AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Danaher Corporation AAV Affinity Chromatography Resins Product Offerings
7.2.5 Danaher Corporation Recent Developments
7.3 Repligen Corporation
7.3.1 Repligen Corporation Company Information
7.3.2 Repligen Corporation Introduction and Business Overview
7.3.3 Repligen Corporation AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Repligen Corporation AAV Affinity Chromatography Resins Product Offerings
7.3.5 Repligen Corporation Recent Developments
7.4 Merck KGaA
7.4.1 Merck KGaA Company Information
7.4.2 Merck KGaA Introduction and Business Overview
7.4.3 Merck KGaA AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Merck KGaA AAV Affinity Chromatography Resins Product Offerings
7.4.5 Merck KGaA Recent Developments
7.5 ChromaGenix LLC
7.5.1 ChromaGenix LLC Company Information
7.5.2 ChromaGenix LLC Introduction and Business Overview
7.5.3 ChromaGenix LLC AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 ChromaGenix LLC AAV Affinity Chromatography Resins Product Offerings
7.5.5 ChromaGenix LLC Recent Developments
7.6 Shanghai Duoning Biotechnology Co., Ltd.
7.6.1 Shanghai Duoning Biotechnology Co., Ltd. Company Information
7.6.2 Shanghai Duoning Biotechnology Co., Ltd. Introduction and Business Overview
7.6.3 Shanghai Duoning Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Shanghai Duoning Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Product Offerings
7.6.5 Shanghai Duoning Biotechnology Co., Ltd. Recent Developments
7.7 Changzhou Smart-Lifesciences Biotechnology Co., Ltd.
7.7.1 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. Company Information
7.7.2 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. Introduction and Business Overview
7.7.3 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Product Offerings
7.7.5 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. Recent Developments
7.8 Shanghai Yaonuo Biotechnology Co., Ltd.
7.8.1 Shanghai Yaonuo Biotechnology Co., Ltd. Company Information
7.8.2 Shanghai Yaonuo Biotechnology Co., Ltd. Introduction and Business Overview
7.8.3 Shanghai Yaonuo Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Shanghai Yaonuo Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Product Offerings
7.8.5 Shanghai Yaonuo Biotechnology Co., Ltd. Recent Developments
7.9 Kangyuan Medical Technology Dalian Co., Ltd.
7.9.1 Kangyuan Medical Technology Dalian Co., Ltd. Company Information
7.9.2 Kangyuan Medical Technology Dalian Co., Ltd. Introduction and Business Overview
7.9.3 Kangyuan Medical Technology Dalian Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Kangyuan Medical Technology Dalian Co., Ltd. AAV Affinity Chromatography Resins Product Offerings
7.9.5 Kangyuan Medical Technology Dalian Co., Ltd. Recent Developments
7.10 Shangchun Biotechnology Wuhan Co., Ltd.
7.10.1 Shangchun Biotechnology Wuhan Co., Ltd. Company Information
7.10.2 Shangchun Biotechnology Wuhan Co., Ltd. Introduction and Business Overview
7.10.3 Shangchun Biotechnology Wuhan Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Shangchun Biotechnology Wuhan Co., Ltd. AAV Affinity Chromatography Resins Product Offerings
7.10.5 Shangchun Biotechnology Wuhan Co., Ltd. Recent Developments
8 Industry Chain Analysis
8.1 AAV Affinity Chromatography Resins Industrial Chain
8.2 AAV Affinity Chromatography Resins Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 AAV Affinity Chromatography Resins Sales Model
8.5.2 Sales Channels
8.5.3 AAV Affinity Chromatography Resins Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global AAV Affinity Chromatography Resins market size was US$ 13.06 million in 2025 and is forecast to reach a readjusted size of US$ 32.06 million by 2032 with a CAGR of 13.3% during the forecast period 2026-2032.
Published Date: 2026-07-31
Pages: 130
USD 4250.00
(Single User License)
The global AAV Affinity Chromatography Resins market is projected to grow from US$ 13.06 million in 2025 to US$ 32.06 million by 2032, at a CAGR of 13.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-31
Pages: 137
USD 4900.00
(Single User License)
The global AAV Affinity Chromatography Resins market was valued at US$ 13.06 million in 2025 and is anticipated to reach US$ 32.06 million by 2032, at a CAGR of 13.3% from 2026 to 2032.
Published Date: 2026-07-31
Pages: 111
USD 2900.00
(Single User License)
The global AAV Affinity Chromatography Resins market size was US$ 13.06 million in 2025 and is forecast to reach a readjusted size of US$ 32.06 million by 2032 with a CAGR of 13.3% during the forecast period 2026-2032.
Published: 2026-07-31
Pages: 130
The global AAV Affinity Chromatography Resins market is projected to grow from US$ 13.06 million in 2025 to US$ 32.06 million by 2032, at a CAGR of 13.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-31
Pages: 137
The global AAV Affinity Chromatography Resins market was valued at US$ 13.06 million in 2025 and is anticipated to reach US$ 32.06 million by 2032, at a CAGR of 13.3% from 2026 to 2032.
Published: 2026-07-31
Pages: 111
REPORT COVERAGE
Key Findings
Market Trends
Market Segmentation
Market Dynamics
Industry Chain Analysis
Segment Insights
Downstream Market Opportunities
Regional Insights
Competitive Landscape Analysis
Report Scope
Chapter Outline
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research